BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33770101)

  • 21. Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs.
    Nghiem PP; Hoffman EP; Mittal P; Brown KJ; Schatzberg SJ; Ghimbovschi S; Wang Z; Kornegay JN
    Am J Pathol; 2013 Nov; 183(5):1411-24. PubMed ID: 24160322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.
    Xu R; Camboni M; Martin PT
    Neuromuscul Disord; 2007 Mar; 17(3):209-20. PubMed ID: 17300937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
    Xu R; DeVries S; Camboni M; Martin PT
    Am J Pathol; 2009 Jul; 175(1):235-47. PubMed ID: 19498002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of N-glycolylneuraminic acid (Neu5Gc) and cytotoxic T cell (CT) carbohydrate expression in normal and dystrophin-deficient dog and human skeletal muscle.
    Martin PT; Golden B; Okerblom J; Camboni M; Chandrasekharan K; Xu R; Varki A; Flanigan KM; Kornegay JN
    PLoS One; 2014; 9(2):e88226. PubMed ID: 24505439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy.
    Terrill JR; Duong MN; Turner R; Le Guiner C; Boyatzis A; Kettle AJ; Grounds MD; Arthur PG
    Redox Biol; 2016 Oct; 9():276-286. PubMed ID: 27611888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs.
    Araujo KP; Bonuccelli G; Duarte CN; Gaiad TP; Moreira DF; Feder D; Belizario JE; Miglino MA; Lisanti MP; Ambrosio CE
    PLoS One; 2013; 8(4):e61367. PubMed ID: 23579193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvessel density in muscles of dogs with golden retriever muscular dystrophy.
    Nguyen F; Guigand L; Goubault-Leroux I; Wyers M; Cherel Y
    Neuromuscul Disord; 2005 Feb; 15(2):154-63. PubMed ID: 15694137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.
    Barthélémy I; Calmels N; Weiss RB; Tiret L; Vulin A; Wein N; Peccate C; Drougard C; Beroud C; Deburgrave N; Thibaud JL; Escriou C; Punzón I; Garcia L; Kaplan JC; Flanigan KM; Leturcq F; Blot S
    Skelet Muscle; 2020 Aug; 10(1):23. PubMed ID: 32767978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transduction of full-length dystrophin to multiple skeletal muscles improves motor performance and life span in utrophin/dystrophin double knockout mice.
    Kawano R; Ishizaki M; Maeda Y; Uchida Y; Kimura E; Uchino M
    Mol Ther; 2008 May; 16(5):825-31. PubMed ID: 18334987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
    Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
    Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GRMD cardiac and skeletal muscle metabolism gene profiles are distinct.
    Markham LW; Brinkmeyer-Langford CL; Soslow JH; Gupte M; Sawyer DB; Kornegay JN; Galindo CL
    BMC Med Genomics; 2017 Apr; 10(1):21. PubMed ID: 28390424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy.
    Nghiem PP; Bello L; Stoughton WB; López SM; Vidal AH; Hernandez BV; Hulbert KN; Gourley TR; Bettis AK; Balog-Alvarez CJ; Heath-Barnett H; Kornegay JN
    Yale J Biol Med; 2017 Sep; 90(3):351-360. PubMed ID: 28955176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
    Martin PT; Xu R; Rodino-Klapac LR; Oglesbay E; Camboni M; Montgomery CL; Shontz K; Chicoine LG; Clark KR; Sahenk Z; Mendell JR; Janssen PM
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C476-88. PubMed ID: 19109526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN; Peterson JM; Bogan DJ; Kline W; Bogan JR; Dow JL; Fan Z; Wang J; Ahn M; Zhu H; Styner M; Guttridge DC
    Skelet Muscle; 2014; 4():18. PubMed ID: 25789154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic?
    Kerkis I; Ambrosio CE; Kerkis A; Martins DS; Zucconi E; Fonseca SA; Cabral RM; Maranduba CM; Gaiad TP; Morini AC; Vieira NM; Brolio MP; Sant'Anna OA; Miglino MA; Zatz M
    J Transl Med; 2008 Jul; 6():35. PubMed ID: 18598348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative dystrophin gene transcripts in golden retriever muscular dystrophy.
    Schatzberg SJ; Anderson LV; Wilton SD; Kornegay JN; Mann CJ; Solomon GG; Sharp NJ
    Muscle Nerve; 1998 Aug; 21(8):991-8. PubMed ID: 9655116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.